Member Spotlight: Michael J. Smith

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

In The News: Coronavirus Vaccines for Kids Under 5 Are Finally Here

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

In The News: Proportion of Black, Hispanic Physicians Do Not Reflect US Population

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

PIDS Foundation News: Michael Pichichero (Donor)

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

President’s Letter from Dr. C. Buddy Creech – Goals For PIDS; Goals With PIDS

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

In The News: Antibiotic Resistance Could Be a Top Cause of Death by 2050, Experts Say

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

In The News – Inappropriate Antibiotics for Nonhospitalized Kids Cost US at Least $74 Million

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

Member Spotlight: Gabriela Maron

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

In The News: As Mysterious Child Hepatitis Cases Swell, Scientists Study Symptoms and Causes

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

In The News: Hospitals Can Reduce Antibiotic Overuse By Avoiding Unnecessary Blood Draws in Critically Ill Children, Study Shows

May. 4, 2022

In The News: FDA Approves Remdesivir to Treat Young Children with COVID-19

CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…

Apr. 26, 2022

PIDS Joins IDSA, HIVMA, SHEA and SIDP in Letter Urging COVID-19 Supplemental Funding Bill

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi and Minority Leader McCarthy: On behalf of the Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), Society for Healthcare…

Apr. 20, 2022

Member Spotlight: Sean O’Leary

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado. Additionally, he is a pediatric infectious diseases specialist, an…

Apr. 20, 2022

In The News: Pandemic Propels Global Efforts to Study Rare Vaccine Side Effects

Science reports on a substantial effort undertaken by scientists from over 20 countries across six continents to gather data for the world’s largest vaccine safety project. Initiated more than a…

Apr. 20, 2022

In The News: PCR Tests Don’t Predict Response to Antibiotics in Coughing Kids

A recent story by Medscape looked at a research study on the recent practice of using polymerase chain reaction (PCR) testing to identify patients with acute cough who have bacterial…

Apr. 20, 2022

PIDS Foundation News: Andi Shane (Donor)

It was during a PIDS retreat during fellowship training that the Society began to impact Andi L. Shane’s career. Surrounded by colleagues who shared her passion for all aspects of…

Apr. 6, 2022

President’s Letter from Dr. C. Buddy Creech – Building a Resilient Society

Whether personal or professional, resilience is an admirable, invaluable trait. The cost of acquiring it, though, often exceeds what we had imagined. Resilience typically requires being challenged beyond what we…

Apr. 6, 2022

In The News: Long-Acting Injectable HIV Regimen for Adolescents

On March 29, the FDA, Healio reports, approved Cabenuva as the first long-acting HIV treatment regimen for adolescents. The approval was supported by studies conducted among adults and data from…

Apr. 6, 2022

In The News: Where US Stands on COVID-19 Vaccines for Children Under 5

US children under 5 years of age remain ineligible for COVID-19 vaccination as the Food and Drug Administration delayed steps toward authorizing the vaccines last month, CNN reports. While children…

Mar. 23, 2022

PIDS Foundation News: Emma Mohr (Award Recipient)

Emma Mohr is an assistant professor in the division of pediatric infectious diseases at the University of Wisconsin-Madison. She currently heads an independent research program in a preclinical model of…

Mar. 23, 2022

In The News: Babies Born to RSV Vaccinated Mothers and Antimicrobial Impact

Citing a study published via PNAS (The Proceedings of the National Academy of Sciences), Medscape reports babies born to mothers who were vaccinated against respiratory syncytial virus while pregnant appear…

Mar. 23, 2022

In The News: Measles Cases Drop During Pandemic

As reported by Medscape, PIDS member Walter Orenstein cautioned a recent plunge in reported cases should not diminish how we perceive the threat posed by measles, or other infectious diseases….

Improving the health of children worldwide through philanthropic support of scientific and educational programs.

This site uses cookies to provide a better experience for you
Ok